Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Tretter 2014 Abstract MiP2014"

From Bioblast
 
(6 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{{Abstract
{{Abstract
|title=Cool or heat? Bioenergetic and ROS homeostatic approach to therapeutic hypothermia. Mitochondr Physiol Network 19.13.
|title=Cool or heat? Bioenergetic and ROS homeostatic approach to therapeutic hypothermia.
|info=[[File:Tretter_L.JPG|150px|right|Tretter L]] [http://www.mitophysiology.org/index.php?mip2014 MiP2014], [[Laner 2014 Mitochondr Physiol Network MiP2014|Book of Abstracts Open Access]]
|info=[[File:Tretter_L.JPG|150px|right|Tretter L]] [[Laner 2014 Mitochondr Physiol Network MiP2014|Mitochondr Physiol Network 19.13]] - [http://www.mitophysiology.org/index.php?mip2014 MiP2014]
|authors=Tretter L, Kovacs K, Adam-Vizi V
|authors=Tretter L, Kovacs K, Adam-Vizi V
|year=2014
|year=2014
Line 7: Line 7:
|abstract=Acute ischemia-reperfusion injury of the brain affects millions of people. Currently there is no really efficient neuroprotective therapy, however, a simple physical procedure, therapeutic hypothermia, can have beneficial effects. Although there is agreement that in this group of diseases oxidative stress is an important factor, the effects of temperature changes on the reactive oxygen species (ROS) formation and on the ROS elimination have not been clarified yet. A few publications in high profile journals claimed that mitochondrial ROS formation was inversely related to increasing temperature. In the present work, the effects of temperature changes on H<sub>2</sub>O<sub>2</sub> formation and elimination were investigated in isolated guinea pig brain mitochondria in association with oxygen consumption.
|abstract=Acute ischemia-reperfusion injury of the brain affects millions of people. Currently there is no really efficient neuroprotective therapy, however, a simple physical procedure, therapeutic hypothermia, can have beneficial effects. Although there is agreement that in this group of diseases oxidative stress is an important factor, the effects of temperature changes on the reactive oxygen species (ROS) formation and on the ROS elimination have not been clarified yet. A few publications in high profile journals claimed that mitochondrial ROS formation was inversely related to increasing temperature. In the present work, the effects of temperature changes on H<sub>2</sub>O<sub>2</sub> formation and elimination were investigated in isolated guinea pig brain mitochondria in association with oxygen consumption.


Mitochondrial ROS production was measured using Amplex UltraRed fluorescence, the rate of H<sub>2</sub>O<sub>2</sub> elimination was measured using a hydrogen peroxide-sensitive electrode (WPI). Oxygen consumption of mitochondria was measured using an OROBOROS Oxygraph-2k. In order to energize mitochondria glutamate plus malate, succinate and alpha-glycerophosphate substrates were used. The bioenergetic and ROS parameters of mitochondria were investigated at 33, 37 and 41 °C.
Mitochondrial ROS production was measured using Amplex UltraRed fluorescence, the rate of H<sub>2</sub>O<sub>2</sub> elimination was measured using a hydrogen peroxide-sensitive electrode (WPI). Oxygen consumption of mitochondria was measured using an Oroboros Oxygraph-2k. In order to energize mitochondria glutamate plus malate, succinate and alpha-glycerophosphate substrates were used. The bioenergetic and ROS parameters of mitochondria were investigated at 33, 37 and 41 °C.


The rate of substrate oxidation showed a strong increase with temperature, whereas the efficiency of oxidation was decreased. Considering the ROS homeostasis both the formation of H<sub>2</sub>O<sub>2</sub> and the elimination of H<sub>2</sub>O<sub>2</sub> became faster with increasing temperature. With Complex I substrates at resting respiration, H<sub>2</sub>O<sub>2</sub> production was increased by 31%, as a consequence of elevating the temperature from 33 °C to 41 °C. Using succinate or alpha-glycerophosphate, results were similar. The biggest difference (59% between 33 °C and 41 °C) was detected when H<sub>2</sub>O<sub>2</sub> production was measured in the presence of the Complex I inhibitor rotenone. The rate of H<sub>2</sub>O<sub>2</sub> elimination was also elevated by 24% with increased temperature (from 33 °C to 41 °C), in glutamate+malate supported mitochondria.  
The rate of substrate oxidation showed a strong increase with temperature, whereas the efficiency of oxidation was decreased. Considering the ROS homeostasis both the formation of H<sub>2</sub>O<sub>2</sub> and the elimination of H<sub>2</sub>O<sub>2</sub> became faster with increasing temperature. With Complex I substrates at resting respiration, H<sub>2</sub>O<sub>2</sub> production was increased by 31%, as a consequence of elevating the temperature from 33 °C to 41 °C. Using succinate or alpha-glycerophosphate, results were similar. The biggest difference (59% between 33 °C and 41 °C) was detected when H<sub>2</sub>O<sub>2</sub> production was measured in the presence of the Complex I inhibitor rotenone. The rate of H<sub>2</sub>O<sub>2</sub> elimination was also elevated by 24% with increased temperature (from 33 °C to 41 °C), in glutamate+malate supported mitochondria.  


Rising the temperature from hypothermic to hyperthermic conditions resulted in an increase in mitochondrial oxygen consumption, H<sub>2</sub>O<sub>2</sub> production and H<sub>2</sub>O<sub>2</sub> elimination. The increase of ROS production was higher than that of H<sub>2</sub>O<sub>2</sub> elimination; thus, according to our results, the elevation of temperature created oxidative stress conditions. We conclude that the neuroprotective effects of therapeutic hypothermia are also based on the decreased rate of mitochondrial H<sub>2</sub>O<sub>2</sub> production.
Rising the temperature from hypothermic to hyperthermic conditions resulted in an increase in mitochondrial oxygen consumption, H<sub>2</sub>O<sub>2</sub> production and H<sub>2</sub>O<sub>2</sub> elimination. The increase of ROS production was higher than that of H<sub>2</sub>O<sub>2</sub> elimination; thus, according to our results, the elevation of temperature created oxidative stress conditions. We conclude that the neuroprotective effects of therapeutic hypothermia are also based on the decreased rate of mitochondrial H<sub>2</sub>O<sub>2</sub> production.
|mipnetlab=HU Budapest Tretter L, HU Budapest Semmelweis Univ
|mipnetlab=HU Budapest Tretter L
}}
}}
{{Labeling
{{Labeling
Line 18: Line 18:
|organism=Guinea pig
|organism=Guinea pig
|tissues=Nervous system
|tissues=Nervous system
|preparations=Isolated Mitochondria
|preparations=Isolated mitochondria
|injuries=RONS; Oxidative Stress, Temperature
|injuries=Oxidative stress;RONS, Temperature
|substratestates=CI, CII
|pathways=N, S
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|event=C4, Oral
|event=C4, Oral

Latest revision as of 13:05, 23 January 2019

Cool or heat? Bioenergetic and ROS homeostatic approach to therapeutic hypothermia.

Link:

Tretter L

Mitochondr Physiol Network 19.13 - MiP2014

Tretter L, Kovacs K, Adam-Vizi V (2014)

Event: MiP2014

Acute ischemia-reperfusion injury of the brain affects millions of people. Currently there is no really efficient neuroprotective therapy, however, a simple physical procedure, therapeutic hypothermia, can have beneficial effects. Although there is agreement that in this group of diseases oxidative stress is an important factor, the effects of temperature changes on the reactive oxygen species (ROS) formation and on the ROS elimination have not been clarified yet. A few publications in high profile journals claimed that mitochondrial ROS formation was inversely related to increasing temperature. In the present work, the effects of temperature changes on H2O2 formation and elimination were investigated in isolated guinea pig brain mitochondria in association with oxygen consumption.

Mitochondrial ROS production was measured using Amplex UltraRed fluorescence, the rate of H2O2 elimination was measured using a hydrogen peroxide-sensitive electrode (WPI). Oxygen consumption of mitochondria was measured using an Oroboros Oxygraph-2k. In order to energize mitochondria glutamate plus malate, succinate and alpha-glycerophosphate substrates were used. The bioenergetic and ROS parameters of mitochondria were investigated at 33, 37 and 41 °C.

The rate of substrate oxidation showed a strong increase with temperature, whereas the efficiency of oxidation was decreased. Considering the ROS homeostasis both the formation of H2O2 and the elimination of H2O2 became faster with increasing temperature. With Complex I substrates at resting respiration, H2O2 production was increased by 31%, as a consequence of elevating the temperature from 33 °C to 41 °C. Using succinate or alpha-glycerophosphate, results were similar. The biggest difference (59% between 33 °C and 41 °C) was detected when H2O2 production was measured in the presence of the Complex I inhibitor rotenone. The rate of H2O2 elimination was also elevated by 24% with increased temperature (from 33 °C to 41 °C), in glutamate+malate supported mitochondria.

Rising the temperature from hypothermic to hyperthermic conditions resulted in an increase in mitochondrial oxygen consumption, H2O2 production and H2O2 elimination. The increase of ROS production was higher than that of H2O2 elimination; thus, according to our results, the elevation of temperature created oxidative stress conditions. We conclude that the neuroprotective effects of therapeutic hypothermia are also based on the decreased rate of mitochondrial H2O2 production.


O2k-Network Lab: HU Budapest Tretter L


Labels: MiParea: Respiration, Patients 

Stress:Oxidative stress;RONS, Temperature  Organism: Guinea pig  Tissue;cell: Nervous system  Preparation: Isolated mitochondria 


Pathway: N, S  HRR: Oxygraph-2k  Event: C4, Oral  MiP2014 

Affiliation

1-Dep Medical Biochem, Semmelweis Univ; 2-MTA-SE Laboratory Neurobiochem, Budapest, Hungary. - [email protected]

Acknowledgements

Supported by OTKA (NK 81983), and Hungarian Academy of Sciences MTA TKI 02001, and Hungarian Brain Research Program - Grant No. KTIA_13_NAP-A-III/6.